- Home
- SOL vs ONCY Comparison
SOL vs ONCY Comparison
Compare SOL & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOL
- ONCY
- Stock Information
- Founded
- SOL 2005
- ONCY 1998
- Country
- SOL United States
- ONCY Canada
- Employees
- SOL N/A
- ONCY N/A
- Industry
- SOL Semiconductors
- ONCY Pharmaceuticals and Biotechnology
- Sector
- SOL Technology
- ONCY Health Care
- Exchange
- SOL Nasdaq
- ONCY Nasdaq
- Market Cap
- SOL 98.5M
- ONCY 106.1M
- IPO Year
- SOL 2008
- ONCY 1999
- Fundamental
- Price
- SOL $1.79
- ONCY $1.02
- Analyst Decision
- SOL Strong Buy
- ONCY Strong Buy
- Analyst Count
- SOL 2
- ONCY 6
- Target Price
- SOL $4.50
- ONCY $6.00
- AVG Volume (30 Days)
- SOL 154.1K
- ONCY 875.7K
- Earning Date
- SOL 11-14-2025
- ONCY 11-12-2025
- Dividend Yield
- SOL N/A
- ONCY N/A
- EPS Growth
- SOL N/A
- ONCY N/A
- EPS
- SOL N/A
- ONCY N/A
- Revenue
- SOL $71,226,000.00
- ONCY N/A
- Revenue This Year
- SOL N/A
- ONCY N/A
- Revenue Next Year
- SOL $45.37
- ONCY N/A
- P/E Ratio
- SOL N/A
- ONCY N/A
- Revenue Growth
- SOL N/A
- ONCY N/A
- 52 Week Low
- SOL $1.04
- ONCY $0.33
- 52 Week High
- SOL $2.30
- ONCY $1.51
- Technical
- Relative Strength Index (RSI)
- SOL 38.62
- ONCY 44.57
- Support Level
- SOL $1.76
- ONCY $0.97
- Resistance Level
- SOL $1.85
- ONCY $1.15
- Average True Range (ATR)
- SOL 0.04
- ONCY 0.06
- MACD
- SOL -0.01
- ONCY 0.00
- Stochastic Oscillator
- SOL 22.14
- ONCY 44.97
About SOL Emeren Group Ltd each representing 10 shares
Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has globalised Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. Majority of revenue is From Electricity Generation. The company operates in China, USA, Germany, UK, Spain, France, Poland, Italy, Hungary, Luxembourg. Majority of revenue is from Italy.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.